Search research articles
Contact Us
Filters
Showing results (11-20 of 77) with videos related to
Page
of 8
Sort By:
Mutation Research
|
November 1, 1989
The mutagenic effect of caprolactam in the spot test with (T x HT) F1 mouse embryos
A Neuhäuser-Klaus, W Lehmacher
Cancer Letters
|
May 1, 1985
Diaplacental carcinogenic effects of 5-azacytidine in NMRI-mice
W Schmahl, E Geber, W Lehmacher
Der Internist
|
April 20, 2002
[ACE inhibitors in high risk heart patients. Primary analysis of the HOPE study]
B Schieffer, H Drexler, W Lehmacher
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement
|
July 13, 2000
Considerations on the statistical design of the ATMI study
R Eisebitt, W Lehmacher, R Lefering
Methods of Information in Medicine
|
January 23, 2015
Drop the Likelihood Ratio. A Novel Non-electronic Tool for Interpreting Diagnostic Test Results
L Herich, W Lehmacher, M Hellmich
Fortschritte Der Medizin
|
February 28, 1992
[Treatment of acute ankle sprains. Comparison of the efficacy and tolerance of 2 indomethacin-gel preparations]
W Diebschlag, W Nocker, W Lehmacher
Biometrics
|
June 1, 1994
Comment on: on the design and analysis of randomized clinical trials with multiple endpoints
W Lehmacher, G Wassmer, P Reitmeir
Biometrics
|
June 1, 1991
Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate
W Lehmacher, G Wassmer, P Reitmeir
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 11, 2016
Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim--correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF
W Lehmacher, M Klasser, A Duering
VASA. Zeitschrift Fur Gefasskrankheiten
|
October 6, 2004
Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV
A Creutzig, W Lehmacher, M Elze
Page
of 8
Search research articles
Search
Showing results (11-20 of 77) with videos related to
Sort By:
Page
of 8
Mutation Research
|
November 1, 1989
The mutagenic effect of caprolactam in the spot test with (T x HT) F1 mouse embryos
A Neuhäuser-Klaus, W Lehmacher
Cancer Letters
|
May 1, 1985
Diaplacental carcinogenic effects of 5-azacytidine in NMRI-mice
W Schmahl, E Geber, W Lehmacher
Der Internist
|
April 20, 2002
[ACE inhibitors in high risk heart patients. Primary analysis of the HOPE study]
B Schieffer, H Drexler, W Lehmacher
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement
|
July 13, 2000
Considerations on the statistical design of the ATMI study
R Eisebitt, W Lehmacher, R Lefering
Methods of Information in Medicine
|
January 23, 2015
Drop the Likelihood Ratio. A Novel Non-electronic Tool for Interpreting Diagnostic Test Results
L Herich, W Lehmacher, M Hellmich
Fortschritte Der Medizin
|
February 28, 1992
[Treatment of acute ankle sprains. Comparison of the efficacy and tolerance of 2 indomethacin-gel preparations]
W Diebschlag, W Nocker, W Lehmacher
Biometrics
|
June 1, 1994
Comment on: on the design and analysis of randomized clinical trials with multiple endpoints
W Lehmacher, G Wassmer, P Reitmeir
Biometrics
|
June 1, 1991
Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate
W Lehmacher, G Wassmer, P Reitmeir
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 11, 2016
Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim--correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF
W Lehmacher, M Klasser, A Duering
VASA. Zeitschrift Fur Gefasskrankheiten
|
October 6, 2004
Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV
A Creutzig, W Lehmacher, M Elze
Page
of 8